Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Settlement Means New Oversight; Does It Mean A New Marketing Plan?

Sep 14 2009

• By The Pink Sheet

Related Content

Pfizer Forks Over $894 Million To Settle Celebrex/Bextra Litigation

Oct 17 2008

Lilly’s Zyprexa Off-Label Settlement: Record Fine, Routine Compliance Deal

Jan 19 2009

Pfizer's Record-Breaking $2.3 Bil. Settlement With U.S. Attorney Imposes New Restrictions on Corporate Behavior

Sep 07 2009

Whistleblower Suit Documents Pfizer's Fraudulent Marketing Of Bextra

Sep 07 2009

Pfizer Sues Oregon To Block Release Of Documents In Bextra/Celebrex Probe

Feb 09 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window